Head and Neck Cancers: Epidemiology Forecast to 2026
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Head and neck cancers usually begin in the squamous cells that line the moist mucosal surfaces of the tissues and organs of the head and neck—more than 83% of all oral cavity and pharynx cancers are squamous cell carcinomas. They are the ninth most common malignancy in the world, with high mortality rates in the developing countries
10-year epidemiological forecasts of the diagnosed incident cases of HNCs are provided. HNCs are grouped into the following, in this report:
1. Cancers of the lip, oral cavity, pharynx, and larynx cancer (ICD-10 = C00–C06, C09–C10, C12–C14, and C32)
2. Oropharynx cancer (ICD-10 = C10)
3. Nasopharynx cancer (ICD-10 = C11)
4. Other head and neck cancer sites – salivary gland and nose, sinuses, and other related structures cancer (ICD-10 = C07–C08 and C30–C31)
To forecast the diagnosed incident cases and the five-year diagnosed prevalent cases of HNCs in the 7MM, GlobalData epidemiologists selected nationally representative, population-based studies or cancer registries that provided the diagnosed incidence or observed or relative survival rates for these cancers in the 7MM. GlobalData estimate that the diagnosed incident cases of HNCs in the 7MM will increase from 154,300 cases in 2016 to 177,034 cases in 2026, at an Annual Growth Rate (AGR) of 1.47% over the forecast period. Throughout the forecast period, the US will have the highest number of diagnosed incident cases of HNCs, followed by Japan.
Scope
The Head and Neck Cancers Epidemiology Report and Model provide an overview of the risk factors and global trends of head and neck cancers in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
10-year epidemiological forecasts of the diagnosed incident cases of HNCs are provided and segmented into the following groups: cancers of the lip, oral cavity, pharynx, and larynx cancer; oropharynx cancer; nasopharynx cancer; and other sites. Histology distribution and, clinical stage at diagnosis, risk factors, and diagnosed five-year prevalent cases are available for some of the groups.
The head and neck cancers epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
• The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
• The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
The head and neck cancers Epidemiology series will allow you to:
Develop business strategies by understanding the trends shaping and driving the global head and neck cancers market.
Quantify patient populations in the global head and neck cancers market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for head and neck cancers therapeutics in each of the markets covered.
Understand magnitude of patient groups in each of the cancer subgroups and their relevant patient characteristics.
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.